Abstract

Mercaptopurine 50-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2006 - Sports Medicine

Page(s): 64

Download in electronic PDF format for $75
  • Mercaptopurine 50-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Mercaptopurine 50-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • mercaptopurine
  • Crohn's disease
  • inflammatory bowel disease
  • lymphocytic leukemia

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • GASTROENTEROLOGY
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2006
Pg. 64
Mercaptopurine 50-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jan/Feb 2018
Pg. 51
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 234
Mercaptopurine 75-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2013
Pg. 380-383
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Author(s): McElhiney Linda F
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2002
Pg. 16-18
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Author(s): Vail Jane
Jan/Feb 2016
Pg. 81-85
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Author(s): Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Jul/Aug 2011
Pg. 336
Cromolyn Sodium 50-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Jul/Aug 2000
Pg. 276-279
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Author(s): Glasnapp Andrew, Schaefer Erin
Sep/Oct 2002
Pg. 367
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 378-384
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Author(s): Narváez Katherine Rivera, Thompson Tara
Nov/Dec 2006
Pg. 453
Chloral Hydrate 50-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 461
Valacyclovir 50-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A